Autonomix Completes Licensing Transaction for FDA-Cleared Ablation Technology
24. Juli 2024 08:00 ET
|
Autonomix Medical, Inc.
RF Innovations’ Apex 6 Generator aligns with specifications required for Autonomix’s ablation system and facilitates ongoing development Transaction further reinforces Autonomix’s FDA regulatory...
Intuity Medical’s POGO Automatic®, the First and Only FDA-Cleared Automatic Blood Glucose Monitor, Now Covered by Medicare Part B
02. Mai 2024 08:00 ET
|
Intuity Medical
FREMONT, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Intuity Medical, Inc., a medical technology company committed to making it easier to live with diabetes, announced today that its POGO Automatic®...
Intuity Medical is Providing Insured People with Diabetes Easier Access to POGO Automatic Through HealthHavenRx™ eCommerce Partnership
11. April 2024 09:00 ET
|
Intuity Medical
FREMONT, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Intuity Medical, Inc., the medical technology company committed to making it easier to live with diabetes, is announcing a partnership with...
AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
11. April 2023 09:00 ET
|
AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO, CA, April 11, 2023 ...
BrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive Disorder (OCD)
13. Oktober 2020 09:00 ET
|
BrainsWay
CRESSKILL, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
BrainsWay to Participate in Virtual Conferences Elevate by Psych Congress Virtual Experience and Online Obsessive-Compulsive Disorder (OCD) in July 2020
21. Juli 2020 09:00 ET
|
BrainsWay Ltd.
PATTERSON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
30. Januar 2020 07:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
27. Januar 2020 07:00 ET
|
Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced initial sales of SofPulse® units into a VA hospital in...
Amedica Receives Positive Nasdaq Listing Decision
01. Dezember 2017 09:00 ET
|
Amedica Corporation
SALT LAKE CITY, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform...
Amedica Announces Adjournment of Special Meeting of Stockholders
03. Oktober 2017 10:25 ET
|
Amedica Corporation
SALT LAKE CITY,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative medical device company that develops and commercializes silicon nitride, announced that the...